{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:25Z","timestamp":1793110945319,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00467-025-06956-2","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:01:09Z","timestamp":1758776469000},"page":"1583-1588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["New prognostic markers for IgA nephropathy in children"],"prefix":"10.1007","volume":"41","author":[{"given":"Chiara","family":"Casuscelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Maressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Spinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Peritore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-6559","authenticated-orcid":false,"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"6956_CR1","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/ckj\/sfad199","volume":"16","author":"M Lee","year":"2023","unstructured":"Lee M, Suzuki H, Nihei Y, Matsuzaki K, Suzuki Y (2023) Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis. Clin Kidney J 16:ii1\u2013ii8","journal-title":"Clin Kidney J"},{"key":"6956_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194501","volume":"10","author":"B Knoppova","year":"2021","unstructured":"Knoppova B, Reily C, King RG, Julian BA, Novak J, Green TJ (2021) Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment. J Clin Med 10:4501","journal-title":"J Clin Med"},{"key":"6956_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41390-022-02080-1","volume":"93","author":"N Zhou","year":"2023","unstructured":"Zhou N, Wang H, Wang XY, Jiang YP, Fu Q, Liang Y, Feng GS, Futang Research Center of Pediatric Development (2023) Characteristics of children with IgA nephropathy. Pediatr Res 93:715\u2013719","journal-title":"Pediatr Res"},{"key":"6956_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000495751","volume":"5","author":"R Coppo","year":"2019","unstructured":"Coppo R (2019) Pediatric IgA nephropathy in Europe. Kidney Dis (Basel) 5:182\u2013188","journal-title":"Kidney Dis (Basel)"},{"key":"6956_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","volume":"179","author":"SJ Barbour","year":"2019","unstructured":"Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC, International IgA Nephropathy Network (2019) Evaluating a new international risk-prediction tool in IgA nephropathy. JAMA Intern Med 179:942\u2013952","journal-title":"JAMA Intern Med"},{"key":"6956_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.kint.2022.02.042","volume":"102","author":"SJ Barbour","year":"2022","unstructured":"Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Er L, Reich HN, Barratt J, Cattran DC, International IgA Nephropathy Network (2022) Application of the international IgA nephropathy prediction tool one or two years post-biopsy. Kidney Int 102:160\u2013172","journal-title":"Kidney Int"},{"key":"6956_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.kint.2020.10.033","volume":"99","author":"SJ Barbour","year":"2021","unstructured":"Barbour SJ, Coppo R, Er L, Russo ML, Liu ZH, Ding J, Katafuchi R, Yoshikawa N, Xu H, Kagami S, Yuzawa Y, Emma F, Cambier A, Peruzzi L, Wyatt RJ, Cattran DC, International IgA Nephropathy Network (2021) Updating the international IgA nephropathy prediction tool for use in children. Kidney Int 99:1439\u20131450","journal-title":"Kidney Int"},{"key":"6956_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/ndt\/gfy302","volume":"35","author":"R Coppo","year":"2020","unstructured":"Coppo R, D\u2019Arrigo G, Tripepi G et al (2020) Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford classification for IgA nephropathy (VALIGA) update. Nephrol Dial Transplant 35:1002\u20131009","journal-title":"Nephrol Dial Transplant"},{"key":"6956_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00467-020-04486-7","volume":"36","author":"R Coppo","year":"2021","unstructured":"Coppo R (2021) Treatment of IgA nephropathy in children: a land without KDIGO guidance. Pediatr Nephrol 36:491\u2013496","journal-title":"Pediatr Nephrol"},{"key":"6956_CR10","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.ekir.2023.09.020","volume":"8","author":"DC Cattran","year":"2023","unstructured":"Cattran DC, Floege J, Coppo R (2023) Evaluating progression risk in patients with immunoglobulin A nephropathy. Kidney Int Rep 8:2515\u20132528","journal-title":"Kidney Int Rep"},{"key":"6956_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00467-016-3390-9","volume":"32","author":"R Coppo","year":"2017","unstructured":"Coppo R (2017) Biomarkers and targeted new therapies for IgA nephropathy. Pediatr Nephrol 32:725\u2013731","journal-title":"Pediatr Nephrol"},{"key":"6956_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572754","volume":"11","author":"H Selvaskandan","year":"2020","unstructured":"Selvaskandan H, Shi S, Twaij S, Cheung CK, Barratt J (2020) Monitoring immune responses in IgA nephropathy: biomarkers to guide management. Front Immunol 11:572754","journal-title":"Front Immunol"},{"key":"6956_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/ped.13461","volume":"60","author":"Y Kawasaki","year":"2018","unstructured":"Kawasaki Y, Maeda R, Ohara S, Suyama K, Hosoya M (2018) Serum IgA\/C3 and glomerular C3 staining predict severity of IgA nephropathy. Pediatr Int 60:162\u2013167","journal-title":"Pediatr Int"},{"key":"6956_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.21037\/tp-21-90","volume":"10","author":"Y Lang","year":"2021","unstructured":"Lang Y, Song S, Zhao L, Yang Y, Liu T, Shen Y, Wang W (2021) Serum IgA\/C3 ratio and glomerular C3 staining predict progression of IgA nephropathy in children. Transl Pediatr 10:666\u2013672","journal-title":"Transl Pediatr"},{"key":"6956_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1331-0","volume":"20","author":"WY Gong","year":"2019","unstructured":"Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H (2019) High serum IgA\/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria. BMC Nephrol 20:150","journal-title":"BMC Nephrol"},{"key":"6956_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089707","volume":"9","author":"J Nakata","year":"2014","unstructured":"Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Yanagawa H, Matsuzaki K, Horikoshi S, Novak J, Tomino Y (2014) Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One 9:e89707","journal-title":"PLoS One"},{"key":"6956_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40620-020-00725-0","volume":"33","author":"R Coppo","year":"2020","unstructured":"Coppo R, Robert T (2020) IgA nephropathy in children and in adults: two separate entities or the same disease? J Nephrol 33:1219\u20131229","journal-title":"J Nephrol"},{"key":"6956_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","volume":"55","author":"K Kiryluk","year":"2023","unstructured":"Kiryluk K, Sanchez-Rodriguez E, Zhou XJ et al (2023) Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet 55:1091\u20131105","journal-title":"Nat Genet"},{"key":"6956_CR19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2215\/CJN.13711118","volume":"14","author":"P Chen","year":"2019","unstructured":"Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, Liu L, Lv J, Zhang H (2019) Plasma galactose-deficient IgA1 and C3 and CKD progression in IgA nephropathy. Clin J Am Soc Nephrol 14:1458\u20131465","journal-title":"Clin J Am Soc Nephrol"},{"key":"6956_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1681\/ASN.2012010053","volume":"23","author":"F Berthoux","year":"2012","unstructured":"Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23:1579\u20131587","journal-title":"J Am Soc Nephrol"},{"key":"6956_CR21","doi-asserted-by":"publisher","first-page":"e980812014","DOI":"10.1371\/journal.pone.0098081","volume":"9","author":"H Yanagawa","year":"2014","unstructured":"Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y (2014) A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PLoS One 9:e980812014","journal-title":"PLoS ONE"},{"key":"6956_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/17530059.2013.856878","volume":"7","author":"MC Hastings","year":"2013","unstructured":"Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J, Wyatt RJ (2013) Biomarkers in IgA nephropathy: relationship to pathogenetic hits. Expert Opin Med Diagn 7:615\u2013627","journal-title":"Expert Opin Med Diagn"},{"key":"6956_CR23","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/ndt\/gfr448","volume":"26","author":"J Novak","year":"2011","unstructured":"Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ (2011) IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrol Dial Transplant 26:3451\u20133457","journal-title":"Nephrol Dial Transplant"},{"key":"6956_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.kint.2021.09.023","volume":"101","author":"A Cambier","year":"2022","unstructured":"Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Desch\u00eanes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC (2022) Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy. Kidney Int 101:274\u2013287","journal-title":"Kidney Int"},{"key":"6956_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/ki.2010.314","volume":"78","author":"MT Vuong","year":"2010","unstructured":"Vuong MT, Hahn-Zoric M, Lundberg S, Gunnarsson I, van Kooten C, Wramner L, Seddighzadeh M, Fernstr\u00f6m A, Hanson L\u00c5, Do LT, Jacobson SH, Padyukov L (2010) Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int 78:1281\u20131287","journal-title":"Kidney Int"},{"key":"6956_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbacli.2016.02.002","volume":"5","author":"RN Moresco","year":"2016","unstructured":"Moresco RN, Speeckaert MM, Zmonarski SC, Krajewska M, Komuda-Leszek E, Perkowska-Ptasinska A, Gesualdo L, Rocchetti MT, Delanghe SE, Vanholder R, Van Biesen W, Delanghe JR (2016) Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and Henoch-schonlein purpura nephritis. BBA Clin 5:79\u201384","journal-title":"BBA Clin"},{"key":"6956_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57324-8","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, Li T, Si R, Chen J, Qu Z, Jiang Y (2020) Increased frequency of PD-1(hi)CXCR5(-) T cells and B cells in patients with newly diagnosed IgA nephropathy. Sci Rep 10:492","journal-title":"Sci Rep"},{"key":"6956_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ekir.2022.12.023","volume":"8","author":"W Zhao","year":"2023","unstructured":"Zhao W, Feng S, Wang Y, Wang C, Ren P, Zhang J, Yu L, Zhang C, Bai L, Chen Y, Zhou Q, Qu L, Chen J, Jiang H (2023) Elevated urinary IL-6 predicts the progression of IgA nephropathy. Kidney Int Rep 8:519\u2013530","journal-title":"Kidney Int Rep"},{"key":"6956_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163891","volume":"20","author":"R Bartucci","year":"2019","unstructured":"Bartucci R, Salvati A, Olinga P, Boersma YL (2019) Vanin 1: its physiological function and role in diseases. Int J Mol Sci 20:3891","journal-title":"Int J Mol Sci"},{"key":"6956_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051265","volume":"11","author":"M Mizerska-Wasiak","year":"2022","unstructured":"Mizerska-Wasiak M, P\u0142atos E, Cicho\u0144-Kawa K, Demkow U, Pa\u0144czyk-Tomaszewska M (2022) The usefulness of vanin-1 and periostin as markers of an active autoimmune process or renal fibrosis in children with IgA nephropathy and IgA vasculitis with nephritis-a pilot study. J Clin Med 11:1265","journal-title":"J Clin Med"},{"key":"6956_CR31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J (2015) Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 26:1503\u20131512","journal-title":"J Am Soc Nephrol"},{"key":"6956_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40620-015-0245-6","volume":"29","author":"MR Daha","year":"2016","unstructured":"Daha MR, van Kooten C (2016) Role of complement in IgA nephropathy. J Nephrol 29:1\u20134","journal-title":"J Nephrol"},{"key":"6956_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040495","volume":"7","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Koo HM, Lim BJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Doh FM, Park JT, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH (2012) Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One 7:e40495","journal-title":"PLoS One"},{"issue":"2","key":"6956_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40620-022-01363-4","volume":"36","author":"M Xie","year":"2023","unstructured":"Xie M, Zhu Y, Wang X, Ren J, Guo H, Huang B, Wang S, Wang P, Liu Y, Liu Y (2023) Zhang J (2023) Predictive prognostic value of glomerular C3 deposition in IgA nephropathy. J Nephrol 36:495\u2013505","journal-title":"J Nephrol"},{"key":"6956_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10157-021-02034-7","volume":"25","author":"D Wu","year":"2021","unstructured":"Wu D, Li X, Yao X, Zhang N, Lei L, Zhang H, Tang M, Ni J, Ling C, Chen Z, Chen X, Liu X (2021) Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy. Clin Exp Nephrol 25:641\u2013651","journal-title":"Clin Exp Nephrol"},{"key":"6956_CR36","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","volume":"17","author":"A Roos","year":"2006","unstructured":"Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724\u20131734","journal-title":"J Am Soc Nephrol"},{"key":"6956_CR37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00467-017-3610-y","volume":"32","author":"RCG Fabiano","year":"2017","unstructured":"Fabiano RCG, de Almeida Ara\u00fajo S, Bambirra EA, Oliveira EA, Sim\u00f5es E Silva AC, Pinheiro SVB (2017) Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy. Pediatr Nephrol 32:1211\u20131220","journal-title":"Pediatr Nephrol"},{"key":"6956_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00467-019-04445-x","volume":"35","author":"C Dumont","year":"2020","unstructured":"Dumont C, M\u00e9rouani A, Ducruet T, Benoit G, Clermont MJ, Lapeyraque AL, Phan V, Patey N (2020) Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-schonlein purpura. Pediatr Nephrol 35:843\u2013850","journal-title":"Pediatr Nephrol"},{"key":"6956_CR39","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1681\/ASN.2022020189","volume":"33","author":"J Zhao","year":"2022","unstructured":"Zhao J, Bai M, Ning X, Qin Y, Wang Y, Yu Z, Dong R, Zhang Y, Sun S (2022) Expansion of Escherichia-Shigella in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy. J Am Soc Nephrol 33:2276\u20132292","journal-title":"J Am Soc Nephrol"},{"key":"6956_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141289","volume":"7","author":"EG Currie","year":"2022","unstructured":"Currie EG, Coburn B, Porfilio EA et al (2022) Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses. JCI Insight 7:e141289","journal-title":"JCI Insight"},{"key":"6956_CR41","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.kint.2020.12.028","volume":"99","author":"IZA Pawluczyk","year":"2021","unstructured":"Pawluczyk IZA, Didangelos A, Barbour SJ, Er L, Becker JU, Martin R, Taylor S, Bhachu JS, Lyons EG, Jenkins RH, Fraser D, Molyneux K, Perales-Pat\u00f3n J, Saez-Rodriguez J, Barratt J (2021) Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression. Kidney Int 99:1127\u20131139","journal-title":"Kidney Int"},{"key":"6956_CR42","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.ekir.2021.05.018","volume":"6","author":"I Pawluczyk","year":"2021","unstructured":"Pawluczyk I, Nicholson M, Barbour S, Er L, Selvaskandan H, Bhachu JS, Barratt J (2021) A pilot study to predict risk of IgA nephropathy progression based on miR-204 expression. Kidney Int Rep 6:2179\u20132188","journal-title":"Kidney Int Rep"},{"key":"6956_CR43","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40620-022-01498-4","volume":"36","author":"SP Kademani","year":"2023","unstructured":"Kademani SP, Nelaturi P, Sathyasagar K, Ravikumar S (2023) Noncoding RNAs associated with IgA nephropathy. J Nephrol 36:911\u2013923","journal-title":"J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06956-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:03:16Z","timestamp":1777946596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06956-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6956"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06956-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}